Get started
SYNGENE INTERNATIONAL LIMITEDSYNGENE INTERNATIONAL LIMITEDSYNGENE INTERNATIONAL LIMITED

SYNGENE INTERNATIONAL LIMITED

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Options

SYNGENE trade ideas

stock at support range to buyNote - One of the best forms of Price Action is to not try to predict at all. Instead of that, ACT on the price. So, this chart tells at "where" to act in "what direction. Unless it triggers, like, let's say the candle doesn't break the level which says "Buy if it breaks", You should not buy at all. ======= I use shorthands for my trades. "Positional" - means You can carry these positions and I do not see sharp volatility ahead. (I tally upcoming events and many small kinds of stuff to my own tiny capacity.) "Intraday" -means You must close this position at any cost by the end of the day. "Theta" , "Bounce" , "3BB" or "Entropy" - My own systems. ======= I won't personally follow any rules. If I "think" (It is never gut feel. It is always some reason.) the trade is wrong, I may take reverse trade. I may carry forward an intraday position. What is meant here - You shouldn't follow me because I may miss updating. You should follow the system I share. ======= Like - Always follow a stop loss. In the case of Intraday trades, it is mostly the "Day's High". In the case of Positional trades, it is mostly the previous swings. I do not use Stop Loss most of the time. But I manage my risk with options as I do most of the trades using derivatives Disclaimer: This analysis is for educational purposes only, and I'm not a SEBI registered analyst. If you found this analysis helpful, I encourage you to like and share it. Your observations and comments are also welcomed below. Your support, likes, follows, and comments motivate me to consistently share valuable insights with you.
NSE:SYNGENELong
by thiyaga643
1
Trade Smart in Turbulent Times in SyngeneNSE:SYNGENE , a leading global discovery, development and manufacturing organization catering to the pharmaceutical and biotech industries, is under the spotlight for this week's technical analysis. Entry Logic 🎯: The stock has recently crossed its 50-day moving average (MA) of INR 799, additionally breaching the Fibonacci retracement level of 0.382 at INR 810 . These factors, combined with potential bullish crossovers in Exponential Moving Average Divergence (EMD) and Moving Average Convergence Divergence ( MACD) (12,26,9), lay down a fertile ground for upward movement. The ideal entry point would be upon a strong opening above I NR 810.2 or INR 811.60 (0.5 Fibonacci level). Target Levels 🎯: Target 1: INR 823.45 Target 2: INR 843.70 These targets are set based on historical resistance zones and projected upward momentum. Exit Logic 🚪: An exit should be considered if momentum drops or reverses before reaching the target levels, or upon hitting the targeted price points for desired profits. Stop Loss ⚠️: A stringent stop loss is advised at INR 786. This is a slightly aggressive level aimed at limiting losses should the market sentiment change abruptly. Technical Indicators 📊: MACD: Awaiting a bullish crossover to substantiate entry. Stochastics: Recent crossover observed, bullish sign. RSI: Also in bullish crossover territory. %R: Currently in oversell territory - positive. Fisher 9: Indicating strong buy signal. Market Sentiment 🌐: With the broader Indian market expected to exhibit volatility in the forthcoming week, caution is advisable. The high PE ratio of 64.44 and a modest EPS of 12.06 underscore a relatively high valuation, with a low payout ratio of 4.16. Recommendation 📝: Syngene International presents a potentially lucrative short-term swing trading opportunity for aggressive traders. The anticipated bullish momentum, if actualized, could render fruitful returns; albeit the inherent market risks necessitate a robust exit strategy and a firm stop loss. Disclosures and Disclaimers 📢: This analysis is for informational purposes only and not to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments. The report is based on historical data and prevailing market conditions; the future may unfold differently. All investors are advised to conduct their independent research or consult a financial advisor before making any investment decisions.
NSE:SYNGENELong
by finogent